Addiction treatment intervention: an uncontrolled prospective pilot study of Spiritual Self-Schema therapy with Latina women.
Spiritual Self-Schema (3-S) is a weekly 8-session, mindfulness-based, manual-guided, individual intervention targeting addiction and human immunodeficiency virus (HIV) risk behaviors that integrates cognitive behavioral strategies with Buddhist principles and clients' religious/spiritual beliefs. 3-S is efficacious for reducing drug use and HIV risk behaviors among mixed-gender, methadone-maintained outpatients. The study goal was to conduct a preliminary evaluation of 3-S therapy among urban, low-income Latinas (n = 13) in residential addiction treatment. Data gathered via in-person interviews (baseline, 8 and 20 weeks postentry) showed high rates of 3-S acceptability and positive changes in a number of outcomes relevant to recovery from addiction and to HIV prevention, including impulsivity, spirituality, motivation for change, and HIV prevention knowledge. The study findings are promising; however, a controlled study with longer follow-up is needed to rigorously assess the efficacy of 3-S therapy with Latinas in substance abuse treatment.
Amaro
Hortensia
H
Institute on Urban Health Research, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts 02115, USA. h.amaro@neu.edu
Magno-Gatmaytan
Cielo
C
Meléndez
Michael
M
Cortés
Dharma E
DE
Arevalo
Sandra
S
Margolin
Arthur
A
D000328:Adult; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D015658:HIV Infections / Q000517:prevention & control; D007722:Health Knowledge, Attitudes, Practice; D006630:Hispanic or Latino / Q000523:psychology*; D006801:Humans; D007175:Impulsive Behavior / Q000628:therapy; D019122:Meditation / Q000379:methods*; D001523:Mental Disorders / Q000150:complications / Q000628:therapy*; D010349:Patient Compliance / Q000706:statistics & numerical data; D017060:Patient Satisfaction; D010865:Pilot Projects; D012309:Risk-Taking; D026443:Spiritual Therapies / Q000379:methods*; D019966:Substance-Related Disorders / Q000150:complications / Q000628:therapy*